Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2018-04-11 | Breaux B. Castleman, age 77, has served as a Director of Ionis since June 2013. Since August 2001, Mr. Castleman has been president and chief executive officer of Syntiro Healthcare Services, Inc., a healthcare investment company, which sold its operations as a service provider of integrated care management and disease management. Mr. Castleman was a director of USMD Holdings, Inc., a physician-led integrated healthcare system, from September 2009 until October 2016 and was a director of MELA Sciences, Inc., a medical device company, from 2003 until 2011. The Board believes that Mr. Castleman is uniquely suited to serve on the Board and the Audit Committee because he has significant experience in strategic planning and financial structuring matters for Fortune 1000 companies and has financial advisory expertise in the life sciences industry. In 2017, Mr. Castleman received $67,000 in cash compensation and stock and option awards with an aggregate fair value of $636,941. |
| 2019-04-26 | Breaux B. Castleman, age 78, has served as a Director of Ionis since June 2013. ... The Board believes that Mr. Castleman is uniquely suited to serve on the Board and the Audit Committee because he has significant experience in strategic planning and financial structuring matters for Fortune 1000 companies and has financial advisory expertise in the life sciences industry. |
| 2020-04-24 | Director Compensation for Fiscal 2019 Breaux B. Castleman Cash Compensation Earned or Paid ($): $67,000 Stock Awards ($): $460,728 Option Awards ($): $607,645 All Other Compensation ($): $15,426 Total ($): $1,150,799 |
| 2021-04-23 | Breaux B. Castleman, age 80, has served as a Director of Ionis since June 2013. ... Director Compensation for Fiscal 2020 ... Breaux B. Castleman ... Total ($) $807,397. |
Data sourced from SEC filings. Last updated: 2025-12-06